A Short Evaluation of a New Haematological Analyser: The Cobas Argos 5 Diff by Bas, B. M. et al.
Bas et al.: Evaluation of the Cobas Argos 5 Diff 603
Eur. J. Clin. Chem. Clin. Biochem.
Vol. 31, 1993, pp. 603-608
© 1993 Walter de Gruyter & Co.
Berlin · New York
A Short Evaluation of a New Haematological Analyser:
The Cobas Argos 5 Diff
By B. M. Has, M. J. Catsberg and S. L. K. op de Kamp
Afdeling Hematologie, Maasland Ziekenhuis, Sittard, The Netherlands
(Received October 19, 1992/April 19, 1993)
Summary: In order to evaluate the Cobas Argos 5 Diff, a five-part differential haematological analyser, we
performed a comparative study using our current analyser, the Toa E-5000, and the manual leukocyte
differential. Samples (n = 593) were collected from various departments in our hospital and were tested on
both Cobas Argos 5 Diff and Toa E-5000. Regression lines were calculated for all standard haematological
quantities. A group of 100 samples, including 50 negative (absence of flags) and 50 positive (presence of
flags), on the Cobas Argos 5 Diff were randomly selected from the above-mentioned collection. All these
samples had been checked under the microscope by two persons counting 200 cells each.
The comparison of standard haematological quantities between Cobas Argos 5 Diff and the Toa E-5000
shows good correlation: Red Blood Cells r = 0.993; White Blood Cells r = 0.998; Haemoglobin r = 0.989;
Haematocrit r = 0.982; Thrombocytes r = 0.988; Lymphocytes (%) r = 0.983; Neutrophils (%) r = 0.959.
The correlation between Cobas Argos 5 Diff and the manual leukocyte differential shows good correlation
for lymphocytes and neütrophils, with acceptable correlation for eosinophils. The correlation for basophils
and monocytes was less acceptable, especially for normal samples. We conclude that the efficiency of the
Cobas Argos 5 Diff is good (93%) and that it is a suitable haematological cell analyser.
Introduction
 n , , , i - t t r · *u u ·Such methods are applicable for comparing the basic
The reference for electronic differential leukocyte an- counts, e. g.: red, white cells and platelets, as long as
alyser evaluation is the method established by the the counting systems are based on the same principle.
U. S. National Committee for Clinical Laboratory This is possible today as a majority of counters op-
Standards (NCCLS) (1) named H20-T. This method erate on the aperture impedance method originally
uses as a reference the manual leukocyte differential developed by Coulter,
performed on 150 normal and 150 abnormal spetih
mens, counting 800 cells in each to reduce the subjec- As for the white ceU differential, a comparison be-
tive aspects of the classical 100-cell differential count. tween two different automatic analysers is almost
impossible to interpret statistically because the prin-
The need for haematological analyser evaluation has
 ciples of differential may vary dramatically from one
led several authors to develop their own methods, instrument to another,
which are basically adapted from the H20-T proce-
dure, in order to be more suitable for their own In the latter case, the reference method remains the
laboratories in terms of specimen collection and per- manual leukocyte differential under certain conditions
sonnel. In particular, the methodology developed by described in the literature (5).
Kohut is quite frequently used at this time (2.3).
 X17 A, ~ , A« , . . ^n
 ^
 J
 \ * ^e therefore compared the basic counts from the
A classic way of evaluating a haematological analyser Cobas Argos 5 Diff with ones from a current blood
is to compare the performances of the new one versus cell counter. The white cell differential performances
another one that has proven to be reliable (4). were evaluated versus the manual differential.
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Materials and Methods
System description
The Cobas Argos 5 Diff (manufactured by ABX, France, mem-
ber of the group Hoffmann-La Roche AG) is a fully automatic
blood cell counter and analyser. Whole blood (200 μΐ) is drawn
from a closed tube, from this an aliquot of 25 μΐ is taken
through a ceramic shear valve for performing the count of
platelets, red and white blood cells. The count is performed
using the variation of impedance. Haemoglobin is measured by
a modified haemiglobin cyanide absorbance method.
A second aliquot of 25 μΐ is mixed with a specific reagent that
induces red blood cell lysis and the staining of the eosinophil
granules. The white cells are transferred through a chamber
(ABX patent) where the volume of each cell is measured (var-
iation of impedance), as well as its light absorption (from an
halogen source). From these measurements a chart is plotted.
(X axis = volume; Υ axis = absorbance). The groups of cells
appearing on the chart are lymphocytes, neutrophils, eosino-
phils and monocytes + basophil group.
A third aliquot of 15 μΐ whole blood is mixed with a reagent
which lyses all the cells except the basophils. These are measured
by variation of impedance in a separate chamber. The value
obtained here is substracted from the value of the monocyte -f
basophil group described above.
From the print-out of the results, a sample is declared negative
(normal) if no flag is present. A sample is declared positive
(abnormal) if one or more flags appear.
Specimen collection
Blood samples (n = 593) were collected in Sarstedt monovettes
K2-EDTA. After mixing each sample it was divided of into two
tubes to avoid the problem of different mixing. All the samples
were analysed within two hours after sampling.
Comparison with the Toa-Sysmex E-5000
We compared the performance of the basic counts from the
Cobas Argos 5 Diff with the same from the Toa E-5000 counter
which is currently in use in our lab. The latter has proven to
be reliable in blood cell counting (6).
Reference method
We selected randomly 100 samples (including 50 positive and
50 negative on the Cobas Argos 5 DifT) from the group de-
scribed above and we made blood smears from them. After
drying and staining the blood smears with a Shandon system
according to the May-Grumvald method, 200 cells were counted
twice by two specialists using a double blind method, under
analytical criteria recommended by the NCCLS. If a major
difference between the two counts appears, a third count is
performed on 400 cells.
Statistical calculations
For the calculation of the regression lines we used the proce-
dures and corresponding formula developed by Passing & Bab-
lok (7, 8).
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Fig. 1. Orthogonal regression of the Cobas Argos Versus the ToA E5000 N = 380
a: Red blood cells: Intercept =-0.035, slopec = 0.975; r = 0.993;
b: White blood cells: Intercept = -0.2, slope = 1.000; r = 0.998;
c: Thrombocytes: Intercept = -30.107, slope = 0.929; r = 0.988;
d: Haemoglobin: Intercept = -0.1, slope = 1.000; r = 0.989;
e: Haematocrit: Intercept = -0.007, slope = 0.971; r = 0.982.
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The Passing & Bablok method for calculating the parameters
of the regression line makes no special assumptions regarding
the distribution of the samples and the measurement errors.
The result does not depend on the assignment of the methods
or instruments to X and Y. To obtain reliable results, the
authors recommend assuring the sample size as well as the
sampling distribution, the precision of the methods and the
concentration range covered by the samples.
For the calculation we used a program developed by Boehringer
Mannheim based on the Passing & Bablok formula.
Results
In the first part of our investigation we compared the
results of the normal count of the 593 samples (red
and white blood cells, haematocrit, haemoglobin,
platelets) from the Cobas Argos 5 Diff with those
given by our current counter the Toa System E-5000
(fig. i).
Both analysers were calibrated following the instruc-
tions from the manufacturers.
In the second part of this study, we compared the
performance of the Cobas Argos 5 Diff with that of
the manual leukocyte differential.
We calculated the regression lines between Cobas Ar-
gos and the manual differential for each quantity,
separately for normal and abnormal samples as de-
fined above (figs. 2 and 3).
Sensitivity and specificity
The results were reported as true negative (TN) if the
results from the analyser and the manual leukocyte
differential were both negative; true positive (TP) if
the results from both techniques were positive; false
negative (FN) in cases of negative results given by the
analyser and positive by microscope determination;
false positive (FP) in cases of a positive results re-
ported on the analyser and negative by microscope.
The assessment matrix is shown in table 1.
Different abnormalities found in the positive cases
are compiled in table 2.
Classical indices have been calculated according to
the following formula:
- Specificity = TN/(TN + FP) = 91%
- Sensitivity = TP/(TP + FN) = 96%
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Fig. 2. Orthogonal regression of the Cobas Argos versus the 2 χ 200-cell manual differentiation (Normal samples)
a:
b:
c:
d:
% Neutrophils:
% Lymphocytes:
% Monocytes:
% Eosinophils:
e: % Basinophils:
Intercept
Intercept
intercept
Intercept
Intercept
= +8.99,
= 4-3.7,
= +2.8,
= +0.4,
= +0.49,
slope = 0.812;
slope = 0.80;
slope = 2.0;
slope = 1.025;
slope = 1.64;
r = 0.902;
r = 0.911;
r = 0.099;
r = 0.699;
r = 0.415.
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Fig. 3. Orthogonal regression of the Cobas Argos versus the 2 χ 200-cell manual differentiation (Abnormal samples)
a: % Neutrophils: Intercept = +2.88, slope = 0.933; r = 0.969;
slope = 0.821;b: % Lymphocytes:
c: % Monocytes:
d: % Eosinophils:
e: % Basophils:
Intercept = +0.90,
Intercept = -0.92,
Intercept = —0.1,
Intercept = +1.99,
slope = 4.2;
slope = 1.000;
slope = 1.60;
r = 0.958;
r = 0.386;
r = 0.930;
r = 0.401.
Tab. 1. Evaluation of the Cobas Argos 5 Diff performances
versus the manual leukocyte differential.
Cobas Argos 5 Diff
Negative
(manual leukocyte differential)
Positive
(manual leukocyte differential)
Negative Positive
48
45
Tab. 2. Abnormalities found in the positive cases
η Abnormalities
14
2
13
5
4
3
2
2
5
Left shift
Toxic granules
Neutrophilia
Eosinophilia
Lymphocytosis
Chronic lymphoid leukaemia
Atypical lymphocytes
Monocytosis
Red blood cell abnormalities
— Efficiency
= 93%
TP + TN/(TP + TN + FP + FN)
— Predictive value of a positive result = (PV+) =
TP/(TP + FP) = 90%
— Predictive value of a negative result = (PV—) =
TN/(TN + FN) = 96%
On the Cobas Argos 5 Diff, 5 false positive and 2
false negative samples were found. The false negative
samples on the Cobas Argos 5 Diff were reported on
the manual leukocyte differential with the following
abnormalities:
1) atypical lymphocytes; and
2) virally infected lymphocytes
Discussion
The Cobas Argos 5 Diff has already been compared
shortly with the Technicon H2 by W. Goossens (9),
with special emphasis on precision, linearity and car-
ryover. Globally, in this study, the performances were
found to be in agreement with manufacturer claims,
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which are the usual ones expected for such types of
instrument, except, perhaps, for the white blood cell
linearity curve.
The aim of the present study was to compare the
performance of the Cobas Argos 5 Diff on the basic
counts with our current blood cell counter, the Toa
Sysmex E-5000.
The Toa Sysmex E-5000 is a 3-part differential in-
strument which has given satisfactory performance in
blood cell counting, but it is not an appropriate ref-
erence for testing a 5-part differential analyser.
Nevertheless, performance on the basic counts and
haemoglobin measurement of the Cobas Argos 5 Diff
was evaluated versus the Toa E-5000 by calculating
; the linear regression lines following the original pro-
cedure developed by Passing & Bablok.
These authors have developed a procedure of calcu-
lation and tested it versus the classical method of
calculation. The superiority of their method has been
proven by means of a simulation study and recom-
mendations made by the authors have been carefully
considered in our study: These included minimal sam-
[ pie size, coefficient of variation (CV) on both tech-
niques, ranges and absolute values of the collected
data.
We therefore tested 593 samples. Because the program
we used to calculate the regression line accepts a
maximum of 380 samples, we calculated the regression
lines twice on 380 samples and 213 samples and we
found the same results.
In the same way' we determined the regression lines
separately for both normal and abnormal results in
order to increase the power of the statistical test by
; decreasing the spread of the results.
: The Cobas Argos shows good correlation with the
ι manual leukocyte differential on normal samples for
! lymphocytes and neutrophils; acceptable correlation
for eosinophils; and not very good correlation for
basophils and monocyte populations. Concerning the
I monocytes, since the ranges of the data" for the two
, methods are different (0 to 6.5% for the manual
differential and 2.5 to 11.3% for the Cobas Argos),
statistical comparison between the two methods is not
possible. For basophils, the very low number of this
cell usually found skews statistical calculations.
The correlation between the two methods is also good
on abnormal samples. Concerning the monocytes, the
correlation coefficient is slightly increased because of
the 2 cases of monocytosis included. The higher values
for this quantity make the statistical calculation more
powerful.
During this study we found on the Cobas Argos
slightly higher values for monocyte count versus the
manual leukocyte differential. This is compatible with
what other authors have found on other analysers
(10).
For the determination of sensitivity and specificity of
an haematological analyser versus the manual leu-
kocyte differential, NCCLS, in the procedure named
H20 T, recommends counting 800 cells on a total of
150 normal and 150 abnormal specimens.
This method requires a tremendous amount of work
and several researchers have proposed their own pro-
cedures as an alternative to the H20 T.
Kohut suggests reading 100 cells on 4 different smears
made from the same sample by 4 different technolo-
gists.
According to R mke (\ 1), it is not possible to rely on
100 cell counts due to the high CV's found between
two counts.
Therefore, we have preferred to have 200 cells counted
by two different experienced technicians both reading
the same film. This technique has also already been
used (12). The CV for automatic instruments is usu-
ally better than the CV on the manual differential; by
counting more cells we made the two techniques more
comparable in the sense of Passing & Bablok.
The predictive values, as well as the reasonably low
number of false positive results given by the Cobas
Argos 5 Diff, are equivalent to or better than those
shown by other authors on other 5 differential ana-
lysers (13, 14).
Therefore, we have concluded that the Cobas Argos
5 Diff is a very good analyser for screening.
We are also pleased by the possibility of counting and
differentiating leukocytes under 1.0 χ 109/1. One dis-
advantage was the LCD screen. Instead of being really
walk-away, the instrument forced the operator to stay
in front of it. Another negative point was the tem-
perature regulation of the mixing chamber, a problem
that has since been solved.
In our opinion, the use of haemoglobin reagent may
on occasion cause an environmental problem, which
is a problem that must be solved. The sample tray
must be adapted for all tube formats commercially
available.
In conclusion, the Cobas Argos 5 Diff is a user
friendly, fast and compact analyser, comparing very
well with other analysers of same class. Microscopic
analysis and morphological knowledge will, however,
continue to be very important.
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